Australian Medicines Handbook
Australian Medicines Handbook is an evidence-based independent medicines reference preferred by thousands of clinicians in the Australian healthcare sector.
Our company, AMH Pty Ltd, publishes books and electronic reference resources aimed at improving the quality use of medicines.
An Australian owned company, based in Adelaide, our products are specifically created for health care practitioners across Australia.
Learn more about us...
Peer-reviewed and independent
Our editors are highly-qualified health professionals and our content is extensively peer reviewed.
The AMH Editorial Advisory Committee and reviewers are drawn from Australia’s leading educational and medical institutions.
In order to maintain our independence, we accept no advertising, sponsorship or other forms of support from the pharmaceutical industry.
2020 AMH Children’s Dosing Companion
The July 2020 release of the print and online versions are available now. Changes include new monographs for:
- hydroxycarbamide (hydroxyurea) for the prevention of complications in sickle cell disease
- metoprolol for hypertension
- a new darunavir-based, 4-drug HIV combination.
A new 2-bag regimen for administering acetylcysteine for paracetamol overdose has been recommended by Australian guidelines and replaces the 3-bag regimen, bringing with it improved safety and a faster administration time.
And amongst other changes that keep the information up-to-date, dose changes have occurred with clindamycin (for surgical prophylaxis), dolutegravir (dose for children >6 years), lisdexamfetamine (a lower starting dose), midazolam (IM/IV doses for status epilepticus aligned with APLS algorithm), and tocilizumab (new subcutaneous dose for systemic JIA).